CoChat

Apparent mineralocorticoid excess syndrome: an overview

Open access
Palermo, Mario, Quinkler, Marcus, Stewart, Paul M. · 2004 · Arquivos Brasileiros de Endocrinologia & Metabologia

The DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.

Abstract

Apparent mineralocorticoid excess (AME) syndrome results from defective 11beta-hydroxysteroid dehydrogenase type 2 (11beta-HSD2). This enzyme is co-expressed with the mineralocorticoid receptor (MR) in the kidney and converts cortisol (F) to its inactive metabolite cortisone (E). Its deficiency allows the unmetabolized cortisol to bind to the MR inducing sodium retention, hypokalemia, suppression of PRA and hypertension. Mutations in the gene encoding 11beta-HSD2 account for the inherited form, but a similar clinical picture to AME occurs following the ingestion of bioflavonoids, licorice and carbenoxolone, which are competitive inhibitors of 11beta-HSD2. Reduced 11beta-HSD2 activity may explain the increased sodium retention in preeclampsia, renal disease and liver cirrhosis. Relative deficiency of 11beta-HSD2 activity can occur in Cushing's syndrome due to saturation of the enzyme and explains the mineralocorticoid excess state that characterizes ectopic ACTH syndrome. Reduced placental 11beta-HSD2 expression might explain the link between reduced birth weight and adult hypertension. Polymorphic variability in the HSD11B2 gene in part determines salt sensitivity, a forerunner for adult hypertension onset. AME represents a spectrum of mineralocorticoid hypertension with severity reflecting the underlying genetic defect in the 11beta-HSD2; although AME is a genetic disorder, several exogenous compounds can bring about the symptoms by inhibiting 11beta-HSD2 enzyme. Substrate excess as seen in Cushing's syndrome and ACTH ectopic production can overwhelm the capacity of 11beta-HSD2 to convert F to E, leading up to an acquired form of AME.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1590/s0004-27302004000500015

Cites

70 of 70 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 2 Pathophysiology of apparent mineralocorticoid excess syndrome. The mineralocorticoid receptor (MR) binds aldosterone (A) and cortisol (F) with equal affinity. Plasma F concentrations exceed those of A by a 100-fold. 11 -HSD by inactivating F to E, enables aldosterone to bind to MR. After binding of A to the MR, the A-MR complex binds to DNA hormone response elements and increases transcription of target genes. In the case of impaired 11 HSD2 activity, F binds inappropriately to the MR and increases transcription of MR target genes leading to sodium resorption and potassium excretion.
Figure 2 Pathophysiology of apparent mineralocorticoid excess syndrome. The mineralocorticoid receptor (MR) binds aldosterone (A) and cortisol (F) with equal affinity. Plasma F concentrations exceed those of A by a 100-fold. 11 -HSD by inactivating F to E, enables aldosterone to bind to MR. After binding of A to the MR, the A-MR complex binds to DNA hormone response elements and increases transcription of target genes. In the case of impaired 11 HSD2 activity, F binds inappropriately to the MR and increases transcription of MR target genes leading to sodium resorption and potassium excretion.CC-BY-NC · From the PDF
Image 2
CC-BY-NC · From the PDF
Figure 4 Mutations and their location in the HSD11B2 gene leading to Apparent Mineralocorticoid Excess (AME) syndrome. Exons= gray squares.
Figure 4 Mutations and their location in the HSD11B2 gene leading to Apparent Mineralocorticoid Excess (AME) syndrome. Exons= gray squares.CC-BY-NC · From the PDF
Figure 5 A) (THF+allo-THF)/THE and UFF/UFE are significantly increased both in AME type I and type II. B) 11 -Hydroxysteroid dehydrogenase is saturated by substrate excess. Increase in UFF/UFE ratio depends by the amount of circulating cortisol.
Figure 5 A) (THF+allo-THF)/THE and UFF/UFE are significantly increased both in AME type I and type II. B) 11 -Hydroxysteroid dehydrogenase is saturated by substrate excess. Increase in UFF/UFE ratio depends by the amount of circulating cortisol.CC-BY-NC · From the PDF
Figure 6 Flowsheet with guidelines for detecting Apparent Mineralocorticoid Excess (AME) syndrome. THF= tetrahydrocortisol; aTHF= allo-tetrahydrocortisol; THE= tetrahydrocortisone; UFF= urinary free cortisol; UFE= urinary free cortisone.
Figure 6 Flowsheet with guidelines for detecting Apparent Mineralocorticoid Excess (AME) syndrome. THF= tetrahydrocortisol; aTHF= allo-tetrahydrocortisol; THE= tetrahydrocortisone; UFF= urinary free cortisol; UFE= urinary free cortisone.CC-BY-NC · From the PDF

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 70 references

Research works printed but not linked: 4

  1. Vogt B, 1999, 11beta-Hydroxysteroid dehydrogenase: pathophysiology, Adv Nephrol Necker Hosp, 29, 127
  2. Werder E, 1974, Unusual steroid excretion in a child with low renin hypertension, Res Steroids, 6, 385
  3. Monder C, 1986, The syndrome of apparent mineralocorticoid excess: its association with 11beta-hydroxysteroid dehydrogenase and 5beta-reductase deficiency and some consequences for corticosteroid metabolism, J Clin Endocrinol Metab, 63, 550, 10.1210/jcem-63-3-550 · DOI · Paper page
  4. Nikkila H, 1993, Defect in HSD1 gene encoding 11beta-hydroxysteroid dehydrogenase are not found in patient with mineralocorticoid excess or 11-oxo reductase deficiency, J Clin Endocrinol Metab, 77, 687

Cited by

See all 98

Metadata

Authors
Palermo, M., Quinkler, M., & Stewart, P. M.
Affiliations
  • University of Sassari (IT)
  • University of Birmingham (GB)
Corresponding author
Palermo, Mario
Venue
Arquivos Brasileiros de Endocrinologia & Metabologia
Published
2004-10
Volume
48
Issue
5
Pages
687-696
ISSN
0004-2730 (ISSN-L)
OpenAlex
W2040822167
Cited by
92
References
70
Citations by year
2026: 2 · 2025: 3 · 2024: 4 · 2023: 5 · 2022: 8 · 2021: 4 · 2020: 4 · 2019: 4 · 2018: 3 · 2017: 3 · 2016: 4 · 2015: 3 · 2014: 4 · 2013: 7 · 2012: 4
FWCI
0.33
Type
journal article
Language
en
Open access
Licence
cc-by-nc
Locations
  • Arquivos Brasileiros de Endocrinologia & Metabologia (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (publishedVersion, other-oa)
  • UnissResearch (Università degli Studi di Sassari) (submittedVersion)
  • UnissResearch (Università degli Studi di Sassari) (submittedVersion, other-oa)
  • Americanae (AECID Library) (submittedVersion, other-oa)
  • University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
  • INFM-OAR (INFN Catania) (submittedVersion, other-oa)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
Keywords
apparent mineralocorticoid excess syndrome, 11β-hydroxysteroid dehydrogenase type 2, mineralocorticoid receptor, cortisol metabolism, licorice, carbenoxolone, bioflavonoids, preeclampsia, Cushing's syndrome, ectopic ACTH syndrome, birth weight, salt sensitivity, hypertension, hypokalemia, sodium retention
MeSH terms
Alkalosis, Decision Trees, Humans, Hypertension, Hypokalemia, Plasma Volume, Renin-Angiotensin System, Syndrome, Mineralocorticoid Excess Syndrome, Apparent

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Apparent mineralocorticoid excess syndrome: an overview. https://app.cochat.ai/papers/10.1590/s0004-27302004000500015
The paper
Palermo, M., Quinkler, M., & Stewart, P. M. (2004). Apparent mineralocorticoid excess syndrome: an overview. Arquivos Brasileiros de Endocrinologia & Metabologia. https://doi.org/10.1590/s0004-27302004000500015

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.